Baine Marina K, Rekhtman Natasha
Department of Pathology, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
Transl Lung Cancer Res. 2020 Jun;9(3):860-878. doi: 10.21037/tlcr.2020.02.13.
Pulmonary large cell neuroendocrine carcinoma (LCNEC) is a rare and aggressive malignancy that is strongly linked to smoking and notoriously difficult to diagnose and treat. Recent molecular data reveal that it represents a biologically heterogeneous group of tumors, characterized by morphologic and genomic diversity that straddles small cell and non-small cell lung carcinomas (NSCLCs), and in a minority of cases atypical carcinoids. This review provides an update on recent molecular and clinical developments in LCNEC with the main focus on practical approach to pathologic diagnosis using illustrative examples of the main differential diagnostic considerations.
肺大细胞神经内分泌癌(LCNEC)是一种罕见且侵袭性强的恶性肿瘤,与吸烟密切相关,诊断和治疗 notoriously 困难。最近的分子数据显示,它代表了一组生物学上异质性的肿瘤,其特征是形态学和基因组的多样性,跨越小细胞肺癌和非小细胞肺癌(NSCLC),在少数情况下还包括非典型类癌。本综述提供了LCNEC近期分子和临床进展的最新情况,主要重点是使用主要鉴别诊断考虑因素的示例来说明病理诊断的实用方法。